Epitalon (Epithalan) in Australia: Longevity Research Guide

Epitalon (sequence: Ala-Glu-Asp-Gly, also written as Epithalan) is a synthetic tetrapeptide corresponding to the active sequence of Epithalamin, a polypeptide extract isolated from bovine pineal gland tissue. It was developed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology, where it has been researched since the 1980s as part of a broader programme investigating peptide bioregulators (cytomedins) and their role in ageing.

Epitalon is sometimes grouped with other Khavinson peptides (including Thymalin (thymus-derived), Vilon, and Cortagen) that share a common research philosophy of short peptide bioregulators derived from specific glandular tissues.

The most cited research finding for Epithalan involves telomerase activation. Telomerase (TERT) is the enzyme responsible for maintaining telomere length, the protective caps on chromosomes that shorten with each cell division. Telomere shortening is a hallmark of cellular ageing, and telomerase activity declines in most somatic cells after early development.

Research by Khavinson and colleagues, published in journals including Bulletin of Experimental Biology and Medicine and Neuroendocrinology Letters, has reported:

• Epitalon treatment of human fetal fibroblast cell lines increased telomerase activity and extended the replicative lifespan of the cells beyond the Hayflick limit in vitro
• Epitalon-treated cells maintained telomere length over successive passages compared to untreated controls
• The effect was attributed to upregulation of TERT expression rather than post-translational modification of existing enzyme

It is important to note that the majority of this telomerase research originates from Khavinson's own laboratory, and independent replication in Western peer-reviewed literature remains limited. Researchers should approach the telomerase claims with appropriate scientific scrutiny while noting the volume of Russian-language primary literature supporting them.

As a pineal-derived peptide, Epithalan has been studied for effects on melatonin synthesis and circadian rhythm regulation:

• Melatonin restoration, studies in aged rodents have shown Epitalon administration partially restores the age-related decline in nocturnal melatonin secretion, which is well-documented in both animal and human ageing research
• Circadian normalisation, abnormal circadian rhythms are associated with accelerated ageing and metabolic dysfunction; Epitalon's effects on the pineal-melatonin axis have been studied as a potential mechanism for its broader anti-ageing effects
• Antioxidant activity, melatonin is itself a potent antioxidant; Epitalon-mediated melatonin restoration may contribute to reduced oxidative stress markers observed in treated animal models

Among the most striking claims in the Epithalan literature are lifespan extension studies in animal models:

• Studies in fruit flies (Drosophila melanogaster) reported mean lifespan increases of approximately 11–16% with Epitalon treatment
• Rodent studies have reported reductions in tumour incidence, delayed onset of age-related pathology, and modest lifespan extension in treated animals
• A long-term observational study in elderly humans (the "40-year study" reported by Khavinson) claimed reduced mortality in peptide bioregulator recipients versus controls, though this data has not been published in a form amenable to standard critical evaluation

Epitalon occupies an unusual position in the longevity research space: it has a large body of supporting literature from a single research group, but limited independent validation. It is best approached as a research compound with interesting mechanistic hypotheses and promising preliminary data rather than established clinical evidence.

In research contexts investigating hallmarks of ageing, Epithalan is sometimes studied alongside other longevity-focused compounds including NAD+ (for sirtuin and PARP pathway research) and MOTS-c (for mitochondrial signalling). Each addresses different proposed mechanisms of ageing (telomere dynamics (Epithalan), NAD+ depletion (NAD+), and mitochondrial metabolic decline (MOTS-c)) making them complementary tools in multi-mechanism ageing research.

See also: NAD+ research guide → | MOTS-c research guide →

OzPeps stocks research-grade Epithalan with fast AU shipping and discreet packaging. View Epitalon stock and pricing →

Epithalan is sold strictly for in-vitro laboratory research purposes. Not TGA-approved. Not for human or animal consumption. The longevity and telomerase research cited in this article is primarily from preclinical and in-vitro models; human clinical evidence is limited. Researchers are responsible for all applicable regulatory compliance.